Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ford

Showing results (791-800 of 807) with videos related to

Pageof 81
Sort By:
British Journal of Pharmacology|June 16, 1999
In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonistsT J Williams, D R Blue, D V Daniels, et al.
Journal of Parkinson'S Disease|August 30, 2024
Cognitive Effects of Three β-Adrenoceptor Acting Drugs in Healthy Volunteers and Patients with Parkinson's DiseasePepijn P N M Eijsvogel, Laura G J M Borghans, Samantha Prins, et al.
FEBS Letters|March 7, 1998
Molecular cloning, genomic characterization and expression of novel human alpha1A-adrenoceptor isoformsD J Chang, T K Chang, S S Yamanishi, et al.
Journal of the International AIDS Society|July 13, 2019
Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defectsLynne M Mofenson, Anton L Pozniak, Jacque Wambui, et al.
Plos One|June 18, 2026
High performance of point-of-care rapid tests for advanced HIV disease diagnosis by lay providers in Malawi: Results from a prospective diagnostic accuracy study supporting decentralized advanced HIV disease screeningAgness Thawani, Ethel Rambiki, Jacqueline Huwa, et al.
Molecular Biology and Evolution|June 12, 2024
Ancient and Recent Hybridization in the Oreochromis Cichlid FishesAdam G Ciezarek, Tarang K Mehta, Angela Man, et al.
Lancet (London, England)|November 20, 2012
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trialDavid Neal Franz, Elena Belousova, Steven Sparagana, et al.
Nature|May 7, 2025
Heterogeneous pericoerulear neurons tune arousal and exploratory behavioursAndrew T Luskin, Li Li, Xiaonan Fu, et al.
Nature Communications|July 2, 2024
A chemogenetic approach for dopamine imaging with tunable sensitivityMarie A Labouesse, Maria Wilhelm, Zacharoula Kagiampaki, et al.
Journal of Medicinal Chemistry|August 15, 1997
N-arylpiperazinyl-N'-propylamino derivatives of heteroaryl amides as functional uroselective alpha 1-adrenoceptor antagonistsT R Elworthy, A P Ford, G W Bantle, et al.
Pageof 81

Showing results (791-800 of 807) with videos related to

Sort By:
Pageof 81
British Journal of Pharmacology|June 16, 1999
In vitro alpha1-adrenoceptor pharmacology of Ro 70-0004 and RS-100329, novel alpha1A-adrenoceptor selective antagonistsT J Williams, D R Blue, D V Daniels, et al.
Journal of Parkinson'S Disease|August 30, 2024
Cognitive Effects of Three β-Adrenoceptor Acting Drugs in Healthy Volunteers and Patients with Parkinson's DiseasePepijn P N M Eijsvogel, Laura G J M Borghans, Samantha Prins, et al.
FEBS Letters|March 7, 1998
Molecular cloning, genomic characterization and expression of novel human alpha1A-adrenoceptor isoformsD J Chang, T K Chang, S S Yamanishi, et al.
Journal of the International AIDS Society|July 13, 2019
Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defectsLynne M Mofenson, Anton L Pozniak, Jacque Wambui, et al.
Plos One|June 18, 2026
High performance of point-of-care rapid tests for advanced HIV disease diagnosis by lay providers in Malawi: Results from a prospective diagnostic accuracy study supporting decentralized advanced HIV disease screeningAgness Thawani, Ethel Rambiki, Jacqueline Huwa, et al.
Molecular Biology and Evolution|June 12, 2024
Ancient and Recent Hybridization in the Oreochromis Cichlid FishesAdam G Ciezarek, Tarang K Mehta, Angela Man, et al.
Lancet (London, England)|November 20, 2012
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trialDavid Neal Franz, Elena Belousova, Steven Sparagana, et al.
Nature|May 7, 2025
Heterogeneous pericoerulear neurons tune arousal and exploratory behavioursAndrew T Luskin, Li Li, Xiaonan Fu, et al.
Nature Communications|July 2, 2024
A chemogenetic approach for dopamine imaging with tunable sensitivityMarie A Labouesse, Maria Wilhelm, Zacharoula Kagiampaki, et al.
Journal of Medicinal Chemistry|August 15, 1997
N-arylpiperazinyl-N'-propylamino derivatives of heteroaryl amides as functional uroselective alpha 1-adrenoceptor antagonistsT R Elworthy, A P Ford, G W Bantle, et al.
Pageof 81